目的探讨选择性支气管动脉灌注化疗对肺癌治疗的缓解率和缓解时间。
Objective To further study the remission rate and the remission time of the patients with advanced lung cancer treated by selective bronchial arterial infusion.
目的评价选择性支气管动脉灌注化疗(BAIC)治疗癌性上腔静脉综合征(SVCS)的效果。
Objective To evaluate the efficacy of selective bronchial artery infusion chemotherapy (BAIC) in the treatment of cancerous superior vena cava syndrome (SVCS).
结果本组46例中晚期肺癌病人施行154例次选择性支气管动脉造影和灌注化疗。
Results 154 times of bronchial arteriography and BAI with chemotherapeutic agent were performed in 46 pulmonary carcinomas patients.
目的：选择性支气管动脉药物灌注治疗不能手术之中晚期肺癌并观察其疗效。
Purpose:To treat middle-late stage lung cancers which are inoperatible hy selective bronchial artery drug infusion and to study the curative effects.
超选择性支气管动脉栓塞化疗是治疗晚期NSCLC的一种安全有效的方法，其疗效优于静脉注射和单纯支气管动脉灌注化疗。
Superselective bronchial artery chemoembolization is effective and safe for NSCLC, Its response is superior to intravenous chemotherapy and simply bronchial artery infusion.
超选择性支气管动脉栓塞化疗是治疗晚期NSCLC的一种安全有效的方法，其疗效优于静脉注射和单纯支气管动脉灌注化疗。
Superselective bronchial artery chemoembolization is effective and safe for NSCLC, Its response is superior to intravenous chemotherapy and simply bronchial artery infusion.
应用推荐